Janus Henderson Group PLC Raises Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Janus Henderson Group PLC increased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 10.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 86,286 shares of the medical instruments supplier’s stock after acquiring an additional 8,092 shares during the period. Janus Henderson Group PLC owned approximately 1.59% of Mesa Laboratories worth $11,379,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Franklin Resources Inc. boosted its position in shares of Mesa Laboratories by 27.8% in the third quarter. Franklin Resources Inc. now owns 6,444 shares of the medical instruments supplier’s stock worth $828,000 after acquiring an additional 1,403 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Mesa Laboratories by 29.3% in the third quarter. JPMorgan Chase & Co. now owns 8,406 shares of the medical instruments supplier’s stock worth $1,092,000 after acquiring an additional 1,906 shares during the last quarter. Pacer Advisors Inc. boosted its position in shares of Mesa Laboratories by 4.3% in the fourth quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier’s stock worth $231,000 after acquiring an additional 73 shares during the last quarter. Conestoga Capital Advisors LLC boosted its position in shares of Mesa Laboratories by 8.3% in the fourth quarter. Conestoga Capital Advisors LLC now owns 573,037 shares of the medical instruments supplier’s stock worth $75,566,000 after acquiring an additional 43,927 shares during the last quarter. Finally, Sei Investments Co. boosted its position in shares of Mesa Laboratories by 246.2% in the fourth quarter. Sei Investments Co. now owns 5,411 shares of the medical instruments supplier’s stock worth $714,000 after acquiring an additional 3,848 shares during the last quarter. 90.60% of the stock is owned by institutional investors and hedge funds.

Mesa Laboratories Price Performance

MLAB opened at $122.42 on Friday. The company’s 50 day simple moving average is $118.33 and its 200 day simple moving average is $126.66. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. Mesa Laboratories, Inc. has a 1 year low of $83.68 and a 1 year high of $155.12. The stock has a market capitalization of $665.23 million, a PE ratio of -2.65 and a beta of 0.97.

Mesa Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 30th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.64 dividend on an annualized basis and a yield of 0.52%. Mesa Laboratories’s dividend payout ratio (DPR) is -1.38%.

Insider Buying and Selling at Mesa Laboratories

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of Mesa Laboratories stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total transaction of $2,602,110.00. Following the transaction, the chief executive officer now directly owns 43,337 shares of the company’s stock, valued at $5,369,887.67. The trade was a 32.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 4.40% of the stock is currently owned by corporate insiders.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.